[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![ReutersLegal Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::334944709.png) Reuters Legal [@ReutersLegal](/creator/twitter/ReutersLegal) on x 100.1K followers
Created: 2025-07-24 22:40:12 UTC

Swiss drugmaker Novartis will pay up to $X billion to U.S. biotech Matchpoint Therapeutics to develop oral drugs for several inflammatory diseases.

![](https://pbs.twimg.com/card_img/1948360060540723200/DwNK5bju?format=jpg&name=800x419)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948513575502246134/c:line.svg)

**Related Topics**
[drugs](/topic/drugs)
[swiss](/topic/swiss)
[novartis](/topic/novartis)
[$novnsw](/topic/$novnsw)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/ReutersLegal/status/1948513575502246134)